CAU
ASTH icon

Caxton Associates (UK)’s Astrana Health ASTH Stock Holding History

Caxton Associates (UK)’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,458
Closed -$534K – 964
2025
Q2 		$534K Buy
+21,458
New +$604K 0.01% 412

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Caxton Associates (UK)'s ASTH Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 21,458 shares — an estimated $534K sold.

Caxton Associates (UK) first reported a position in ASTH in Q2 2025 and held it in 1 quarter. The position peaked at $534K in Q2 2025. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Caxton Associates (UK) reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 21,458 Astrana Health shares in Q3 2025, an estimated $534K.
  • Caxton Associates (UK) first reported a position in Astrana Health in Q2 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Astrana Health position peaked at $534K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.